You will be redirected to the website of our parent company, Schönherr Rechtsanwälte GmbH : www.schoenherr.eu
Schoenherr's healthcare group draws on a breadth of experience across the firm's practice areas. We combine specialist knowledge and experience with the insights and track-record of our market-leading transactional practice.
Our healthcare & life sciences team covers a wide range of subjects, including pharmaceuticals, biochemistry, chemicals, e-health, cosmetics, medical devices, toys, tobacco products, food and feed.
Partners Andreas Natterer and Paweł Halwa lead and coordinate the Schoenherr expert team. We act for and advise all stakeholders active in the healthcare, life sciences, biotech and pharma sectors. Areas of particular expertise are regulatory life sciences work and transactional advice regarding targets in the healthcare and life sciences industry.
Working closely and in integrated teams with specialists in:
Our full-service offering in the healthcare & life sciences sector covers:
Our advisory covers inter alia:
Hungarian government adopts new decree to tackle shrinkflation
Most of us have likely encountered a situation where we bought our favourite chocolate at the grocery store, only to be surprised upon opening it at home to find that the size and weight of the chocolate had decreased, while the packaging and price remained unchanged.
2024
CEE
CEE team
Youth and beauty (on the edge between cosmetics and medicine)
When prompted to list the top 10 human fears, an OpenAI language model started with the fear of death and ended with the fear of rejection. The AI's advice on how to overcome these fears was clearcut: accept the impermanence of life and find meaning.
The coronavirus presents us with completely new challenges. With the coronavirus info corner we aim to provide specifics about certain legal aspects surrounding Covid-19.
Schoenherr's healthcare & life sciences team consists of experienced lawyers across all our CEE offices.